ZYN002 (cannabidiol)

cannabidiol · Zynerba Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZYN002 (cannabidiol), covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome [Phase 3]